MAYZENT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Siponimod.
| Product ID | 0078-0986_10891f4a-a4d8-4d40-ae51-16cc9e104d36 |
| NDC | 0078-0986 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MAYZENT |
| Generic Name | Siponimod |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-03-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209884 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | SIPONIMOD |
| Active Ingredient Strength | 2 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-03-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209884 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-26 |
| Marketing Category | NDA |
| Application Number | NDA209884 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-03-26 |
| Ingredient | Strength |
|---|---|
| SIPONIMOD | 2 mg/1 |
| SPL SET ID: | 44492772-5aed-4627-bd85-e8e89f308bb3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0979 | MAYZENT | siponimod |
| 0078-0986 | MAYZENT | siponimod |
| 0078-1014 | MAYZENT | siponimod |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MAYZENT 87816240 5846370 Live/Registered |
Novartis AG 2018-03-01 |
![]() MAYZENT 79261592 not registered Live/Pending |
NOVARTIS AG 2019-05-03 |
![]() MAYZENT 79156316 4714545 Live/Registered |
Novartis AG 2014-09-12 |
![]() MAYZENT 79043338 3441076 Dead/Cancelled |
Novartis AG 2007-08-31 |